Summarized by Masters of Longevity from Lifespan.io.
Time-restricted eating and intermittent fasting are examined in a pilot clinical study for people with early Huntington’s, offering a hopeful preview of clinical and biomarker-focused research readers can explore.
Key Takeaways
- Twenty early-stage Huntington’s patients completed a three-month time-restricted eating pilot without a control group.
- The Unified Huntington’s Disease Rating Scale composite improved by an average of 0.50 points versus the expected annual decline.
- Plasma neurofilament light fell with a mean individual reduction of 12.6%, suggesting reduced neuronal injury markers.
